Inventor Profile – Shahram Shahidi Z: ZANA-Salvita-1 Anti-Cancer Bioactive Therapy (Concept Summary)

Project Overview ZANA-Salvita-1 is an innovative early-stage bioactive formulation concept based on natural salt-tolerant cellular structures and rare algae found near Adelaide, South Australia. This injectable candidate therapy is designed in principle to support the body’s own regulatory systems, stimulate cellular intelligence, and promote selective apoptosis (programmed cell death) in harmful or mutated cells, while aiming to minimise impact on healthy tissue. Current stage of development ZANA-Salvita-1 is a pre-clinical, research-level concept. The formulation has not yet undergone clinical trials, regulatory evaluation, or approval, and no medical claims of safety or efficacy are made in this profile. The purpose of this record is to document the conceptual framework, origin of the idea, and inventor profile for future scientific collaboration, simulation studies, and potential experimental development. Inventor Shahram Shahidi Z (ZANA Research Institute – Independent Innovation Division), Melbourne, Australia.